Genprex Statistics

Total Valuation

Genprex has a market cap or net worth of $4.13 million. The enterprise value is -$4.08 million.

Market Cap	4.13M
Enterprise Value	-4.08M

Important Dates

The next estimated earnings date is Monday, August 19, 2024, after market close.

Earnings Date	Aug 19, 2024
Ex-Dividend Date	n/a

Share Statistics

Genprex has 2.10 million shares outstanding. The number of shares has increased by 30.84% in one year.

Shares Outstanding	2.10M
Shares Change (YoY)	+30.84%
Shares Change (QoQ)	+8.80%
Owned by Insiders (%)	1.67%
Owned by Institutions (%)	6.82%
Float	2.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.47
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.42, with zero debt.

Current Ratio	2.42
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -272.70% and return on invested capital (ROIC) is -317.54%.

Return on Equity (ROE)	-272.70%
Return on Assets (ROA)	-198.10%
Return on Capital (ROIC)	-317.54%
Revenue Per Employee	n/a
Profits Per Employee	-$1.06M
Employee Count	26
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -94.87% in the last 52 weeks. The beta is -0.53, so Genprex's price volatility has been lower than the market average.

Beta (5Y)	-0.53
52-Week Price Change	-94.87%
50-Day Moving Average	2.35
200-Day Moving Average	6.84
Relative Strength Index (RSI)	38.47
Average Volume (20 Days)	56,590

Short Selling Information

The latest short interest is 83,150, so 3.96% of the outstanding shares have been sold short.

Short Interest	83,150
Short Previous Month	47,252
Short % of Shares Out	3.96%
Short % of Float	3.99%
Short Ratio (days to cover)	0.36

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-27.81M
Pretax Income	-27.63M
Net Income	-27.63M
EBITDA	-27.61M
EBIT	-27.63M
Earnings Per Share (EPS)	-$18.65

Full Income Statement

Balance Sheet

The company has $8.22 million in cash and no debt, giving a net cash position of $8.22 million or $3.92 per share.

Cash & Cash Equivalents	8.22M
Total Debt	n/a
Net Cash	8.22M
Net Cash Per Share	$3.92
Equity (Book Value)	8.76M
Book Value Per Share	4.17
Working Capital	5.42M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$23.10 million and capital expenditures $1,335, giving a free cash flow of -$23.10 million.

Operating Cash Flow	-23.10M
Capital Expenditures	1,335
Free Cash Flow	-23.10M
FCF Per Share	-$14.28

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Genprex does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-30.84%
Shareholder Yield	-30.84%
Earnings Yield	-668.21%
FCF Yield	-558.79%

Analyst Forecast

The average price target for Genprex is $10.00, which is 407.61% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	407.61%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on February 2, 2024. It was a reverse split with a ratio of 1:40.

Last Split Date	Feb 2, 2024
Split Type	Reverse
Split Ratio	1:40

Scores

Altman Z-Score	n/a
Piotroski F-Score	1